COMPANY

OraSure

HQ: Bethlehem, PA source · orasure.com ↗ · Mid-Atlantic

Our offerings include rapid diagnostic tests for COVID-19, HIV, HCV, syphilis, sickle cell, and Ebola, as well as self-collection devices that stabilize DNA and RNA from a wide range of sample types—saliva, oral fluid, urine, skin cells, blood and stool—with more on the horizon. Our Sherlock Biosciences teams in Newton, Mass., and Cambridge and Oxford, U.K., are working to develop an accurate, disposable molecular diagnostics platform that can be used at the point of need, as well as a molecular self-test for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG). From company website Source · Oct 13, 2026

Keywords: diagnostic tests covid molecular diagnostics diagnostics hematology

Profile checked Oct 10, 2026

2NIH grants

NIH awards 2

Annual award amounts. Total $1.1M.

Jul 17, 2012 NIH award 1R44AI096758-01A1 FY2012: $145,915 awarded for that fiscal year; activity R44 (SBIR); PI LEE, STEPHEN R.; recipient as written: ORASURE TECHNOLOGIES, INC., BETHLEHEM, PA. Development of a rapid screening po source ↗
Mar 5, 2001 NIH award 6R44AI043808-03 FY2000: $992,373 awarded for that fiscal year; activity R44 (SBIR); PI GEORGE, J. R; recipient as written: ORASURE TECHNOLOGIES, INC., BETHLEHEM, PA. DEVELOPMENT OF SYPHILLIS EIA ASSAYS FOR source ↗